Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells.
J Control Release
; 369: 658-667, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38604384
ABSTRACT
Granzyme B (GrB)-based immunotherapy is of interest for cancer treatment. However, insufficient cellular uptake and a lack of targeting remain challenges to make use of GrB for solid tumour therapy. As GrB induced cell death requires the help of perforin (PFN), we designed a system (nGPM) for the co-delivery of GrB and PFN. Therefore, GrB and PFN were loaded in a porous polymeric nanocapsule rich in acetylcholine analogues and matrix metalloproteinase-2 (MMP-2) responsive peptides. The neutrally charged nGPM nanocapsules showed as long circulating time and accumulated at the tumour sites. Once in the tumour the outside shell of nanocapsules became degraded by overexpressed MMP-2 proteases, resulting in the release of GrB and PFN. We found that the PFN complex formed small pores on the surface of tumour cells which allow GrB to enter the cytoplasm of tumour cells inducing cell apoptosis and tumour suppression significantly.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Granzimas
/
Nanocápsulas
/
Perforina
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article